Updated Story HHS will appeal a court decision that struck down a Trump administration rule requiring drug makers to disclose list prices in television advertisements, the department said in a court filing on Wednesday (Aug. 21) . The U.S. District Court for the District of Columbia on July 8 ruled that HHS did not have the authority to force drug makers to include list prices in ads. The rule was one of HHS’ marquee drug-pricing policies before...